Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials
- Citation:
- J Clin Oncol vol 41 (2) 336-342
- Year:
- 2023
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-internal-user
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 12
- Parents:
- 3254
- Children:
- None
- Pharmas:
- Celgene (50803); GSK (50901 & 50904)
- Grants:
- U10CA180821, U10CA180882, UG1CA233339, UG1CA233247, UG1CA233253, UG1CA233277, UG1CA233328, U10 CA180819 (SWOG)
- Corr. Author:
- Authors:
- Sarah C. Rutherford Jun Yin Levi Pederson Gabriela Perez Burbano Betsy LaPlant Mazyar Shadman Hongli Li Michael L. LeBlanc Vaishalee P. Kenkre Fangxin Hong Kristie A. Blum Travis Dockter Peter Martin Sin-Ho Jung Barbara Grant Cara Rosenbaum Chaitra Ujjani Paul M. Barr Joseph M. Unger Bruce D. Cheson Nancy L. Bartlett Brad Kahl Jonathan W. Friedberg Sumithra J. Mandrekar John P. Leonard
- Networks:
- CAPITAL, LAPS-IL057, LAPS-MN026, LAPS-MO011, LAPS-OH007, LAPS-WI020, NC012, NY018, NY167, PA121
- Study
- Alliance-A151737
- Multiple Studies, or Legacy Studies in Alliance Study:
- Alliance-A051103, CALGB-50701, CALGB-50801, CALGB-50901, SWOG-S0016, SWOG-S0816
- Phases:
- N/A, 1, 2, 3
- Keywords:
- ORIGINAL REPORTS, Hematologic Malignancy